안지오랩 Stock: price and insider trades · South Korea

안지오랩 belongs to the Health Care sector. Filings by its managers are published through DART (FSS). The last twelve months, up to 10 November 2026, brought 2 filings signed by 2 insiders.

Open-market activity splits into 1 purchase and 1 sale; 1 insider sit on the buying side and 1 insider on the selling side. The amount is not disclosed for 2 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 1 chief executive.

For context, the typical company on the same exchange (median of 2,648 companies) published 7 filings over the same period, against 2 filings here. Since 2021, the database holds 1 purchase and 13 sales by insiders of the company.

The last purchase on record was published on 12 August 2026, which is 90 days ago.

For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Cytosorbents Corp. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.